Navitus, the nation’s first transparent, pass-through pharmacy benefit manager (PBM), released its ninth annual Drug Trend ...

Its deal with the US-based AI-driven drug design and development company will ... The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver ...

Samsung may separate its foundry business from its semiconductor division. This move addresses conflict of interest concerns. It mirrors a similar separation at Samsung Biologics. The foundry business ...

The key to improving SFE in 2025 lies in fundamentally reorienting measurement from representative activities to the value ...

Key complex product approval in the Affordable Medicines segment this yearCommercial launch planned for third quarter of 2025 ...

Juliana Reed - Biosimilars Forum "In order for biosimilars to offer cost-savings of up to 85% discounts on reference product medicines, the industry has had to design and implement one of the most ...

The Mesoblast Ltd (ASX: MSB) share price reached an intraday peak of $1.94 today, which is a 10-week high. Is an upward trend ...

INmune Bio's XPro1595 targets soluble TNF for Alzheimer's. Phase 2 results could reshape inflammatory disease treatment.

Nicoya Lifesciences has acquired Applied Photophysics, a British-based provider of biophysical characterization instruments, ...

Global Phase 3 BRAVE study will evaluate the efficacy and safety of omaveloxolone in children 2 to <16 years old with ...